Here are the top 5 medtech stories of mid-2018

A growing U.S. trade war with China and other countries casts a pall on medtech — and U.S. business in general — in mid-2018. The landscape of the medical device industry continues to evolve, though. There’s a major corporate spinout in the works, as well as a mega-merger that apparently was not to be. Read

Pages: 1 2 3 4 5 6

SetPoint Medical touts 2-year relief from rheumatoid arthritis

Startup SetPoint Medical has demonstrated “significant, sustained improvement” over two years in a first-in-human study using bioelectronic therapy in patients with rheumatoid arthritis (RA). Seventeen subjects with moderate to severe symptoms were implanted with a vagus nerve stimulator in the European study. At three months, the therapy was shown to have significantly reduced RA symptoms

8 companies commercializing transcatheter mitral valve replacements

Transcatheter mitral valve replacement is a new frontier in the cardio device field, with big legacy medical device companies including Edwards Lifesciences, Medtronic and Abbott spending hundreds of millions of dollars on companies in the space. Much different from transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR) has been mostly experimental. TMVR is used

Pages: 1 2 3 4 5 6 7 8 9

Minnesota’s Medical Alley has a big presence at EuroPCR

The Medical Alley Association in Minnesota is touting the major presence that companies and organizations from the state will have at this year’s EuroPCR, which is being held this week in Paris. The event — the European Association of Percutaneous Cardiovascular Interventions’ annual meeting — is May 22–25 at the Palais des Congrès and is expected to

Can Minnesota become a healthcare innovation hub?

Minnesota has the institutions and the talent to transform healthcare in the U.S. The question is whether the money will follow. RxFunction makes wearable devices called “Walkasins” that help people with chronic health conditions prevent falls that can lead to serious injury. It took eight painstaking years, though, before the Eden Prairie, Minn.-based startup secured

Speakers you need to see at DeviceTalks Minnesota

A Google executive whose own heart problems spurred her to seek medtech innovation, a leader at Abbott who wants to drive healthcare value, the head of an upstart company seeking to transform diabetes care — those are but some of the speakers you will encounter at DeviceTalks Minnesota this June. Read on to find out

Pages: 1 2 3 4 5 6 7 8

Webinar: How Boston Scientific selected its PLM medical device software solution

This webinar was presented live on Thursday, May 3, 2018. Click below to watch on demand.     As a global medical device manufacturer, Boston Scientific must balance quality, innovation, compliance, and profitability. This panel discussion provides insight into how Boston Scientific supports those needs. Listen to Tina Kunshier, Boston Scientific and Michelle Boucher, VP

Former GE CEO Jeff Immelt had a lasting impact in medtech: Here’s how

No matter how you feel about his tenure leading the industrial conglomerate, former GE CEO Jeff Immelt helped shape medtech by filling the industry’s corner offices with former employees. The right leader at the right company, at the right time, can have an effect that last decades – not only through their own actions but

The 10 largest medtech employers – and what their workers really think

Among the 10 largest medtech employers, workers feel pride in working on life-saving products – but there’s also frustration with big corporate bureaucracy. That was the major takeaway as Medical Design & Outsourcing compiled some of the most insightful current and former employee reviews posted on Glassdoor. The 10 companies we’re counting down were the

Pages: 1 2 3 4 5 6 7 8 9 10 11

How Boston Scientific is boosting medical device value

Boston Scientific over the summer unveiled a new value-add for its implantable cardio devices: an online Trugevity calculator that lets physicians predict battery life. The idea is to help health providers quickly grasp the benefits of Boston Sci’s longer lasting EnduraLife battery technology, which the company touts has nine clinical studies and eight years of real-world

DeviceTalks: Mike Mahoney – Boston Scientific CEO

Four years ago, when Mike Mahoney was just another rising star in the Johnson & Johnson universe, the powers-that-be at Boston Scientific knew they needed a game-changer. Times were not good at the Natick, Mass.-based medical device giant. For several years following the $27 billion Guidant acquisition, Boston Scientific had been mired in a prolonged